VN February 2026

Vetnews | Februarie 2026 26 « BACK TO CONTENTS It was proposed in the previous swine study that the lack of detectable circulating virus following vaccination likely contributed to the suboptimal humoral immune response. However, the robust humoral immune response observed in vaccinated cattle despite the recapitulation of the viremia results seen earlier in swine suggests that the cause of the reduced humoral immunogenicity of this virus in swine is likely more complex and multifactorial than a lack of circulation and may instead be related to swine immunology or the tropism of the A24-P2/P3Deopt strain. Immunological divergence has been observed between cattle and swine. For example, while IgA+ B cells—a critical contributor to mucosal immunity—are found circulating only in small numbers in swine 37, an analysis of the frequency of expressed sequence tags in GenBank suggests that IgA+ B cells may account for as many as 15% of the circulating B cell population in cattle (unpublished data). A robust circulating double-positive CD4+CD8+ T cell population has also been observed in suids and seems to play a role in immune response to certain pathogens, such as African Swine Fever Virus 38-40 and Japanese encephalitis virus 41, while this population circulates at a much lower frequency in cattle, though may still be relevant to pathogenesis in certain diseases 42. Additionally, the frequency of regulatory T cells (Treg) in cattle has been observed at high levels relative to many other mammalian species 43, while this cell population represents a smaller subset of porcine CD4+ T cells 44,45. Tregs are well known to play a role in virus-host détente and persistence 46, and it has been proposed that they may be important to virus ecology in cattle in the context of FMDV 47. Many differences in FMDV immunity have also been observed over the years. For example, while a strong neutralising antibody titer reliably correlates with a protective immune response in cattle, this is not the case in swine 4850. In cattle immunised with the adenoviral vectored FMDV O1Campos vaccine, the proportion of CD4+ and CD8+ cells expressing IFNγ upon ex vivo restimulation significantly increased following a homologous challenge against which they were protected 51. Similarly, PBMCs isolated from cattle inoculated with the inactivated FMD vaccine either with or without Montanide adjuvant produced significant quantities of IFNγ at 4- and 7-days post-vaccination 5. While the present LAV platform has not demonstrated protective efficacy— even serotype specific—in swine, it is possible that this could be achieved through formulation with adjuvants or using alternative routes of vaccination. While our group found that a preparation of Asia1 Shamir CPD formulated with Montanide did not result in protective efficacy when administered to swine (data not published), novel adjuvants could be assayed. Analogously, novel routes of vaccination that increase potency and safety might be considered, such as microneedle inoculation 52. In addition to demonstrating a strong humoral immune response and excellent efficacy against the parental A24Cruzeiro WT strain, sera from the two-dose 106 and 105 pfu A24-P2/P3Deopt vaccinated groups demonstrated broad neutralisation capacity both within the A serotype and even across serotypes against Asia1. This is consistent with what has been shown historically with a wide variety of live attenuated vaccines 53,54, underscoring the vaccine’s potential for application in ever-evolving outbreak situations. For many of the other strains assayed by serum microneutralization, the amino acid sequence identity of VP1—particularly in hypermutable regions such as the G-H loop and AA43-49, both regions known to interact with integrin during receptor binding and internalisation—did not necessarily concord strongly with the r1 value of the assay. This suggests that other immunodominant epitopes in the capsid may be responsible for driving the broadly neutralising response observed early after vaccination or that successful neutralisation may be more dependent on microhomology within these hypermutable regions, such as the RGD sequence in the G-H loop. When considering O1Manisa, it is possible that the incorporation of charged and polar amino acids well-suited to electrostatic interactions in the G-H loop contributed to the lack of cross-reactivity of the serum antibodies. In addition to the broadly neutralising antibody response elicited by this LAV vaccine, the vector from which the A24P2/P3Deopt virus was derived was engineered with restriction sites flanking the P1 capsid domain, allowing for easy sequence swapping to quickly derive additional vaccine candidates against other serotypes and strains 26. As a result, this platform has the potential to be rapidly adapted to meet local needs in outbreak situations. Currently, the predominant trend in FMD vaccination strategy is to utilise vaccines incorporating purification steps in the production chain or incorporating DIVA markers. Unfortunately, it remains unclear why the DIVA marker included in A24-P2/P3Deopt 26 is not fully effective. Given the error-prone RNA polymerase of this virus, however, it is conceivable that random mutations over serial passage resulted in some reversion to the parental sequence. In their work on a CPD RSV vaccine strain, MIN AL, Levy et al. found significant accumulation of mutations over serial passage, though most were missense mutations that did not result in reversion to virulence 17. However, in their work with MIN AL, they found that reintroduction of a few point mutations was sufficient to reverse virus temperature sensitivity and return growth curves to the levels seen in WT RSV. Conversely, Yeh et al. 55 was able to introduce significant genetic stability over many passages to the Sabin2 live attenuated poliovirus— vaccines notorious for rapid genetic evolution and reversion to virulence—by introducing a small number of mutations in 3 regions of the genome, including mutations in the 5’ UTR to stabilize a temperature sensitivity mutation and move a cis-acting replication element (cre), several synonymous mutations in 2C to disrupt the secondary structure of a cre site and single amino acid substitutions in 3D. For the present FMD vaccine candidate to be attractive for licensing, the issue around DIVA marker stability must be further investigated. Reversion to virulence is always a concern with LAVs, and while recombination events could be initiated in the UTRs or non-deoptimized 3D region of A24-P2/P3Deopt, we have previously shown that the risk of such recombination events is low 56. Additionally, such recombination events would require the presence of the WT virus. Mutations to the 3Dpol gene that increase replication fidelity, such as replacement of W237 with phenylalanine, have resulted in mutants with similar in vitro growth kinetics to WT virus, while achieving a more attenuated in vivo phenotype 57. Such mutations could also be incorporated into future infectious clones, although it has been observed that the non-deoptimized region (conserved because of a proposed RNA structure at this site 58) of the 3Dpol in A24-P2/P3Deopt served as a recombination initiation site when the WT virus was present in vitro 56. While genetic stability over many passages should be assessed, both in vitro and in vivo, recombination events such as this in the field with the WT virus would not result in more virulent strains of virus than the currently circulating WT. The present study demonstrates that our A24-P2/P3Deopt vaccine candidate shows strong promise in cattle as an LAV vaccine. Not only have we established a minimum 3-log safety margin for this strain and a lack of shedding, but A24-P2/P3Deopt also induced full protection and elicited broad cross-neutralising antibody protection. Given these factors and the engineering of this live attenuated virus, this platform could provide an agile tool for outbreak prevention and control. Article Live-attenuated foot-and-mouth disease virus vaccine engineered.... <<< 25

RkJQdWJsaXNoZXIy OTc5MDU=